EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies

Carlos M Gastalho iD, Ana M Sena iD, Óscar López, José G Fernández-Bolaños, Alfonso T García-Sosa iD, Florbela Pereira iD, Célia M Antunes iD, Ana R Costa iD, Anthony J Burke, Elisabete P Carreiro iD

International Journal of Molecular Sciences · 17.10.2024 · 25 (20) · 11153

DOI: 10.3390/ijms252011153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.10.2024. Verfasst von Carlos M Gastalho und 9 weiteren Autor:innen. Beteiligte Einrichtung: LAQV-REQUIMTE, Institute for Research and Advanced Training (IIFA), University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Molecular Docking Simulation, Triazoles, Pyrimidinones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Estonian Research Council, MCIN/AEI/10.13039/501100011033.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combining the pharmacological properties of the 1,2,3-triazole and dihydropyrimidinone classes of compounds, two small families of mono- and di(1,2,3-triazole)-dihydropyrimidinone hybrids, A and B, were previously synthesized. The main objective of this work was to investigate the potential anti-Alzheimer effects of these hybrids. The inhibitory activities of cholinesterases (AChE and BuChE), antioxidant activity, and the inhibitory mechanism through in silico (molecular docking) and in solution (STD-NMR) experiments were evaluated. The 1,2,3-triazole-dihydropyrimidinone hybrids (A and B) showed moderate in vitro inhibitory activity on eqBuChE (IC50 values between 1 and 58.4 μM). The best inhibitor was the hybrid B4, featuring two 1,2,3-triazole cores, which exhibited stronger inhibition than galantamine, with an IC50 of 1 ± 0.1 μM for eqBuChE, through a mixed inhibition mechanism. Among the hybrids A, the most promising inhibitor was A1, exhibiting an IC50 of 12 ± 2 µM, similar to that of galantamine. Molecular docking and STD-NMR experiments revealed the key binding interactions of these promising inhibitors with BuChE. Hybrids A and B did not display Artemia salina toxicity below 100 μM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsMolecular Docking SimulationTriazolesPyrimidinonesButyrylcholinesteraseAnimalsAcetylcholinesteraseHumansComputer SimulationAntioxidants

Stichwörter der Autor:innen

1,2,3-triazoleSTD-NMRantioxidant activitycholinesterasesdihydropyrimidinonedocking

Substanzen

Cholinesterase InhibitorsTriazolesPyrimidinonesButyrylcholinesteraseAcetylcholinesteraseAntioxidants

Autor:innen und Institutionen

  • LAQV-REQUIMTE, Institute for Research and Advanced Training (IIFA), University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.
  • Institute of Earth Sciences, Institute of Research and Advanced Training, University of Évora, 7000-671 Évora, Portugal.
  • Academic Clinical Center of Alentejo, C-TRAIL, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.
  • Department of Chemistry and Biochemistry, School of Sciences and Technologies, University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.
  • Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Apartado 1203, E-41071 Seville, Spain.
  • Institute of Chemistry, University of Tartu, Ravila 14 A, 50411 Tartu, Estonia.

ORCID-Profile: Carlos M Gastalho, Ana M Sena, Alfonso T García-Sosa, Florbela Pereira, Célia M Antunes, Ana R Costa, Elisabete P Carreiro

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Estonian Research Council
  • MCIN/AEI/10.13039/501100011033
  • Coimbra Chemistry Centre—Institute of Molecular Sciences (CQC-IMS)
  • ICT
  • FCT

Zitieren

APA

Gastalho, C. M., Sena, A. M., López, Ó., Fernández-Bolaños, J. G., García-Sosa, A. T., Pereira, F., Antunes, C. M., Costa, A. R., Burke, A. J., & Carreiro, E. P. (2024). Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies. International Journal of Molecular Sciences, 25(20), 11153. https://doi.org/10.3390/ijms252011153

Vancouver

Gastalho CM, Sena AM, López Ó, Fernández-Bolaños JG, García-Sosa AT, Pereira F, et al. Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies. International Journal of Molecular Sciences. 2024;25(20):11153. doi:10.3390/ijms252011153

BibTeX
@article{Gastalho2024,
  author = {Gastalho, Carlos M and Sena, Ana M and López, Óscar and Fernández-Bolaños, José G and García-Sosa, Alfonso T and Pereira, Florbela and Antunes, Célia M and Costa, Ana R and Burke, Anthony J and Carreiro, Elisabete P},
  title = {Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11153},
  doi = {10.3390/ijms252011153}
}
Kostenlos starten →